Author Relationships With Industry and Other Entities—2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
| Committee Member | Employment | Consultant | Speaker's Bureau | Ownership/Partnership/ Principal | Personal Research | Institutional, Organizational, or Other Financial Benefit | Expert Witness |
|---|---|---|---|---|---|---|---|
| R. Scott Wright, Chair | Mayo Clinic—Professor of Medicine and Consultant in Cardiology | None | None | None | None | None | None |
| Jeffrey L. Anderson,† Vice Chair | Intermountain Medical Center—Associate Chief of Cardiology; University of Utah—Professor of Medicine |
|
| None |
| None | None |
| Cynthia D. Adams | Community Health Network/Community Heart and Vascular —Director, Network Cardiovascular Outcomes and Nursing Research | None | None | None | None | None | None |
| Charles R. Bridges† | University of Pennsylvania Medical Center—Associate Professor of Surgery |
|
| None | None | None | None |
| Donald E. Casey, Jr | Atlantic Health—Chief Medical Officer and Vice President of Quality | None | None | None | None | None | None |
| Steven M. Ettinger | Pennsylvania State University Heart and Vascular Institute—Professor of Medicine and Radiology | None | None | None | None | None | None |
| Francis M. Fesmire | Heart Stroke Center—Director |
| None | None | None |
|
|
| Theodore G. Ganiats | University of California, San Diego—Professor and Interim Chair | None | None | None | None | None | None |
| Hani Jneid | Baylor College of Medicine—Assistant Professor of Medicine | None | None | None | None | None | None |
| A. Michael Lincoff† | Cleveland Clinic—Vice Chairman of Cardiovascular Medicine, Director of C5Research; Professor of Medicine |
| None | None | None | None | |
| Eric D. Peterson† | Duke University Medical Center—Professor of Medicine, Director of Cardiovascular Research |
| None | None | None | None | |
| George J. Philippides | Boston Medical Center—Vice Chair for Clinical Affairs, Cardiovascular Section; Boston University School of Medicine—Associate Professor of Medicine | None | None | None | None | None | None |
| Pierre Theroux† | Montreal Heart Institute |
|
| None |
| None | None |
| Nanette K. Wenger† | Emory University School of Medicine—Professor of Medicine; Grady Memorial Hospital—Chief of Cardiology |
| None | None | None | None | |
| James Patrick Zidar†‡ | University of North Carolina Health Systems—Clinical Professor of Medicine |
| None | None | None | None | None |
This table represents the relationships of committee members with industry and other entities that were reported by authors to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, or ownership of $10 000 or more of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted.
* Significant relationship.
† Recused from voting on Section 3.2. Recommendations for Antiplatelet and Anticoagulant Therapy, and Section 5.2.1. Recommendations for Convalescent and Long-Term Antiplatelet Therapy.
‡ Relationship began after writing effort was complete but before final approval.